Amgen (AMGN) Updates on Micromet (MITI) Tender; 84% of Shares Submitted

Amgen (Nasdaq: AMGN) reports that all conditions to the closing of the tender offer by a wholly owned subsidiary, "Merger Sub", to acquire all outstanding shares of common stock of Micromet, Inc. (Nasdaq: MITI) for $11.00 per share in cash have been satisfied.

The depositary for the Offer has advised Amgen that, as of the expiration of the Offer at 12:00 midnight, New York City time, at the end of Thursday, March 1, 2012, approximately 80,025,097 million Micromet shares had been validly tendered and not withdrawn pursuant to the Offer, which tendered shares represent approximately 83.95 percent of the outstanding shares of Micromet. Amgen has accepted for payment, and expects to promptly pay for, all such tendered shares. In addition, approximately 3,150,586 million additional Micromet shares have been tendered by guaranteed delivery.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Azul (AZUL) Said in Talks With Gol (GOL) Shareholder for Stock-Based Deal - Bloomberg
• Sapiens (SPNS) Launches IntegrateAI
• Renovaro Biosciences (RENB) Appoints Geert Kazemier as the Chairman of its Scientific Advisory Board